Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Swiss pharma giant Roche won approval from the ...
Roche said on Thursday new data showed its big-selling multiple sclerosis treatment Ocrevus was a "highly effective treatment option offering a favourable and consistent benefit risk profile".
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback